Semaglutide 10mg | GLP-1 Receptor Agonist | 99% Purity | Third-Party Tested

Product Overview

Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist peptide consisting of 31 amino acids. This research-grade peptide has been extensively studied in laboratory settings for its molecular interactions with GLP-1 receptors and cellular signaling pathways. Semaglutide is frequently researched alongside Tirzepatide in comparative GLP-1 receptor agonist studies.

Our Semaglutide research peptide is manufactured to the highest standards, with third-party verified purity exceeding 99%. Each vial contains 10mg of lyophilized (freeze-dried) peptide powder, accompanied by a Certificate of Analysis (COA) from an independent laboratory.

Research Applications

Semaglutide has been the subject of numerous peer-reviewed studies examining its role as a GLP-1 receptor agonist. Research has focused on its molecular binding affinity to GLP-1 receptors, cellular signaling mechanisms, and comparative effects with dual incretin receptor agonists. Published studies have investigated Semaglutide’s molecular pathways in cell culture models and laboratory environments.

Research applications include:

• GLP-1 receptor binding studies: Examination of peptide-receptor interactions and binding kinetics in vitro
• Cellular signaling research: Investigation of GLP-1 receptor-mediated cellular responses and signal transduction pathways
• Comparative incretin studies: Often studied alongside Tirzepatide to examine single versus dual incretin receptor activation mechanisms
• Peptide stability analysis: Study of molecular modifications, plasma stability, and extended half-life characteristics

Important: This product is intended for laboratory research use only. It is not approved for human consumption, clinical use, or any diagnostic or therapeutic applications. This product is not intended to diagnose, treat, cure, or prevent any disease.

Product Specifications

• Peptide Name: Semaglutide
• Alternative Names: GLP-1 Receptor Agonist, NN9535
• Amino Acid Length: 31 amino acids (GLP-1 analogue)
• Molecular Formula: C187H291N45O59
• Molecular Weight: 4113.58 g/mol
• Dosage per Vial: 10mg
• Form: Lyophilized (freeze-dried) white powder
• Purity: >99% (verified by third-party HPLC analysis)
• Storage: Store lyophilized peptide at -20°C. After reconstitution, store at 2-8°C and use within 30 days for optimal stability.
• Packaging: Sterile sealed vial with tamper-evident cap

Quality & Purity Guarantee

Every batch of our Semaglutide peptide undergoes rigorous third-party testing to ensure maximum purity and quality:

• HPLC Analysis: High-Performance Liquid Chromatography confirms peptide purity >99%
• Mass Spectrometry: Verifies molecular weight and sequence accuracy
• Certificate of Analysis: Each order includes a COA from an independent, accredited laboratory
• Sterility Testing: Ensures product is free from microbial contamination
• Endotoxin Testing: Confirms safe levels for research applications

We are committed to providing researchers with the highest quality peptides for advancing scientific knowledge.

Frequently Asked Questions

What is Semaglutide?

Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist consisting of 31 amino acids with specific modifications to extend molecular stability. It has been extensively studied in preclinical research settings for its molecular interactions with GLP-1 receptors and intracellular signaling pathways.

What is Semaglutide used for in research?

Semaglutide is used in laboratory research to study GLP-1 receptor binding mechanisms, cellular signaling pathways, and incretin receptor function. Research applications include receptor binding assays, cellular response studies, and comparative analysis with dual incretin agonists like Tirzepatide. This product is for research purposes only and is not intended for human consumption.

How should Semaglutide be stored?

Store lyophilized Semaglutide at -20°C (freezer) for long-term stability. Once reconstituted with bacteriostatic water, store at 2-8°C (refrigerator) and use within 30 days for optimal stability. Avoid repeated freeze-thaw cycles.

Does each vial come with a Certificate of Analysis?

Yes, every batch of our Semaglutide peptide is tested by an independent, third-party laboratory. Each order includes access to the Certificate of Analysis (COA) verifying purity, molecular weight, and quality specifications.

Can Semaglutide be studied alongside Tirzepatide in research?

Yes, Semaglutide and Tirzepatide are frequently studied together in comparative research settings. This allows researchers to examine single GLP-1 receptor activation (Semaglutide) versus dual GIP/GLP-1 receptor activation (Tirzepatide) mechanisms. All research should be conducted in controlled laboratory environments by qualified personnel.

What is the difference between 5mg and 10mg Semaglutide vials?

Both the 5mg and 10mg Semaglutide vials contain the same high-purity peptide (>99%). The 10mg vial provides a higher concentration for research protocols requiring larger quantities or extended study periods. Both formats are lyophilized powder with identical quality standards and third-party COA verification.

Research Disclaimer

FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.

This product is sold exclusively for research and laboratory purposes. Semaglutide is not approved by the FDA for human use, clinical applications, or any diagnostic or therapeutic purposes when sold as a research peptide. This product is not intended to diagnose, treat, cure, or prevent any disease. Researchers should follow all applicable laws, regulations, and institutional guidelines when handling this material.

By purchasing this product, you acknowledge that you are a qualified researcher or acting on behalf of a research institution, and that this peptide will be used solely for in-vitro or laboratory research purposes.

Related Research Peptides

Researchers studying Semaglutide may also be interested in these complementary peptides:

• Tirzepatide (Dual GIP/GLP-1 Receptor Agonist) – Dual incretin receptor agonist frequently studied alongside Semaglutide for comparative mechanism research
• Semaglutide 5mg – Lower dosage option of the same GLP-1 receptor agonist for smaller-scale research protocols
• BPC-157 (Body Protection Compound-157) – Tissue research peptide with complementary molecular mechanisms
• CJC-1295 (Growth Hormone-Releasing Peptide) – GHRH analogue for growth hormone pathway research